Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease

References

• Cerutti, A., Zan, H., Schaffer, A., Bergsagel, L., Harindranath, N., Max, E.E. and Casali, P. (1998) "CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM±IgD± B cell line", J. Immunol., 2145–2157.
   Google Scholar
• Clark, E.A. and Ledbetter, J.A. (1986) "Activation of human B cells mediated through two distinct cell surface differentiation antigens Bp35 and Bp50", Proc. Natl Acad. Sci. USA 83, 4494–4498.
   PubMed Web of Science ®Google Scholar
• Santos-Argumedo, L., Gordon, J., Heath, A.W. and Howard, M. (1994) "Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest", Cell. Immunol. 156, 272–285.
   Google Scholar
• Gordon, J. (1995) "CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation", Blood Rev. 9, 53–56.
   PubMed Web of Science ®Google Scholar
• Miga, A.J., Masters, SR., Durell, B.G., Gonzalez, M., Jenkins, M.K., Maliszewski, C., Kikutani, H., Wade, WE and Noelle, R.J. (2001) "Dendritic cell longevity and T cell persistence is controlled by CD154—CD40 interactions", Eur. J. Immunol. 31, 959–965.
   Google Scholar
• Randall, T.D., Heath, A.W., Santosargumedo, L., Howard, MC., Weissman, LL. and Lund, F.E. (1998) "Arrest of B lymphocyte terminal differentiation by CD40 signaling—mechanism for lack of antibody-secreting cells in germinal centers", Immunity 8, 733–742.
   PubMed Web of Science ®Google Scholar
• Lee, B.O., Haynes, L., Eaton, S.M., Swain, S.L. and Randall, T.D. (2002) "The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12", J. Exp. Med. 196, 693–704.
   PubMed Web of Science ®Google Scholar
• Howard, L.M. and Miller, S.D. (2001) "Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ", J. Immunol. 166, 1547–1553.
   Google Scholar
• Abromson-Leeman, S., Maverakis, E., Bronson, R. and Dorf, ME. (2001) "CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis", Eur. J. Immunol. 31, 527–538.
   PubMed Web of Science ®Google Scholar
• Becher, B., Durell, B.G., Miga, A.V., Hickey, W.F. and Noelle, R.J. (2001) "The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system", J. Exp. Med. 193, 967–974.
   PubMed Web of Science ®Google Scholar
• Laman, J.D., 't Hart, B.A., Brok, H., Meurs, M., Schellekens, M.M., Kasran, A., Boon, L., Bauer, J., Boer, M. and Ceuppens, J. (2002) "Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)", Eur. J. Immunol. 32, 2218–2228.
   Google Scholar
• Van Kooten, C. and Banchereau, J. (1997) "Functional role of CD40 and its ligand", Int. Arch. Allergy Immunol. 113, 393–399.
   PubMed Web of Science ®Google Scholar
• Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A., Clifford, K.N., Macduff, B.M., Anderson, D.M., Gimpel, S.D., Davis-Smith, T. and Maliszewski, C.R. (1992) "Molecular and biological characterization of a murine ligand for CD40", Nature 357,80–82.
   PubMed Web of Science ®Google Scholar
• Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A. and Gray, D. (1992) "Activated human T cells express a ligand for the human B cell- associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes", Eur. J. Immunol. 22, 2573–2578.
   PubMed Web of Science ®Google Scholar
• Katsiari, C.G., Liossis, S.N., Souliotis, V.L., Dimopoulos, A.M., Manoussalds, M.N. and Sfikakis, RP. (2002) "Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus", Clin. Immunol. 103, 54–62.
   Google Scholar
• Webber, NP., Mascarenhas, J.0., Crow, M.K., Bussel, J. and Schattner, E.J. (2001) "Functional properties of lymphocytes in idiopathic thrombocytopenic purpura", Hum. Immunol. 62, 1346–1355.
   Google Scholar
• Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J. (1994) "Activation of human dendritic cells through CD40 cross-linking", J. Exp. Med. 180, 1263–1272.
   PubMed Web of Science ®Google Scholar
• Van Kooten, C. and Banchereau, J. (2000) "CD4O—CD40 ligand", J. Leukoc. Biol. 67, 2–17.
   PubMed Web of Science ®Google Scholar
• Papadopoulos, E.J., Sassetti, C., Saeki, H., Yamada, N., Kawamura, T., Fitzhugh, D.J., Saraf, M.A., Schall, T., Blauvelt, A., Rosen, S.D. and Hwang, S.T. (1999) "Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation", Eur. J. Immunol. 29, 2551–2559.
   PubMed Web of Science ®Google Scholar
• Sun, Y, Peng, D., Lecanda, J., Schmitz, V., Barajas, M., Qian, C. and Prieto, J. (2000) "In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity", Gene Ther. 7, 1467–1476.
   PubMed Web of Science ®Google Scholar
• Kiener, PA., Moran-Davis, P., Rankin, B.M., Wahl, AF., Aruffo, A. and Hollenbaugh, D. (1995) "Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes", J. Immunol. 155, 4917–4925.
   Google Scholar
• Lu, L., Bonham, CA., Chambers, F.G., Watkins, S.C., Hoffman, R.A., Simmons, R.L. and Thomson, A.W. (1996) "Induction of nitric oxide synthase in mouse dendritic cells by 1FN-ganuna, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis", J. Immunol. 157, 3577–3586.
   Google Scholar
• Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J. and Liu, Y.J. (1995) "Generation of memory B cells and plasma cells in vitro", Science 268, 720–722.
   PubMed Web of Science ®Google Scholar
• Johnson-Leger, C., Christensen, J. and Klaus, G.G. (1998) "CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells", Int. Immunol. 10, 1083–1091.
   PubMed Web of Science ®Google Scholar
• Kwekkeboom, J., de Rijk, D., Kasran, A., Barcy, S., de Groot, C. and de Boer, M. (1994) "Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD4O—CD40 ligand interaction", Eur J. Immunol. 24, 508–517.
   Google Scholar
• Casamayor-Palleja, M., Khan, M. and MacLennan, LC. (1995) "A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex", J. Exp. Med. 181, 1293–1301.
   PubMed Web of Science ®Google Scholar
• Lobo, F.M., Xu, S., Lee, C. and Fuleihan, R.L. (2000) "Transcriptional activity of the distal CD40 ligand promoter", Biochem. Biophys. Res. Commun. 279, 245–250.
   Google Scholar
• Ding, L., Green, J.M., Thompson, C.B. and Shevach, E.M. (1995) "B7/CD28-dependent and -independent induction of CD40 ligand expression", J. Immunol. 155, 5124–5132.
   Google Scholar
• Castle, BE., Kishimoto, K., Stearns, C., Brown, M.L. and Kehry, M.R. (1993) "Regulation of expression of the ligand for CD40 on T helper lymphocytes", J. Immunol. 151, 1777–1788.
   PubMed Web of Science ®Google Scholar
• Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J.A. and Noelle, R.J. (1993) "The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4 + T cells", J. Immunol. 151, 2497–2510.
   PubMed Web of Science ®Google Scholar
• de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P. and Ceuppens, J.L. (1993) "Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells", Eur. J. Immunol. 23, 3120–3125.
   PubMed Web of Science ®Google Scholar
• Peng, X., Remade, J.E., Kasran, A., Huylebroeck, D. and Ceuppens, J.L. (1998) "IL-12 up-regulates CD40 ligand (CD154) expression on human T cells", J. Immunol. 160, 1166–1172.
   PubMed Web of Science ®Google Scholar
• Parra, E., Mustelin, T., Dohlsten, M. and Mercola, D. (2001) "Identification of a CD28 response element in the CD40 ligand promoter", J. Immunol. 166, 2437–2443.
   PubMed Web of Science ®Google Scholar
• Skov, S., Bonyhadi, M., Odum, N. and Ledbetter, J.A. (2000) "IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells", J. Immunol. 164, 3500–3505.
   PubMed Web of Science ®Google Scholar
• Benveniste, EN., Nguyen, VT. and Wesemann, D.R. (2004) "Molecular regulation of CD40 gene expression in macrophages and microglia", Brain Behav. Immun. 18, 7–12.
   PubMedGoogle Scholar
• Fuleihan, R., Ramesh, N., Horner, A., Ahern, D., Belshaw, P.J., Alberg, D.G., Stamenkovic, I., Harmon, W. and Geha, R.S. (1994) "Cyclosporin A inhibits CD40 ligand expression in T lympho-cytes", J. Clin. Investig. 93, 1315–1320.
   PubMed Web of Science ®Google Scholar
• Schubert, L.A., King, G., Cron, R.Q., Lewis, D.B., Aruffo, A. and Hollenbaugh, D. (1995) "The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation", J. Biol. Chem. 270, 29624–29627.
   PubMedGoogle Scholar
• sytsykova, A.V., Tsitsikov, EN. and Geha, R.S. (1996) "The CD4OL promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription", J. Biol. Chem. 271, 3763–3770.
   Google Scholar
• Schubert, L.A., Cron, R.Q., Cleary, A.M., Brunner, M., Song, A., Lu, L.S., Jullien, P., Krensky, A.M. and Lewis, D.B. (2002) "A T cell-specific enhancer of the human CD40 ligand gene", J. Biol. Chem. 277, 7386–7395.
   Google Scholar
• Siddiqa, A., Sims-Mourtada, IC., Guzman-Rojas, L., Rangel, R., Guret, C., Madrid-Marina, V, Sun, Y. and Martinez-Valdez, H. (2001) "Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA", Nature 410, 383–387.
   PubMed Web of Science ®Google Scholar
• Murakami, K., Ma, W., Fuleihan, R. and Pober, J.S. (1999) "Human endothelial cells augment early CD40 ligand expression in activated CD4 + T cells through LFA-3-mediated stabilization of mRNA", J. Immunol. 163, 2667–2673.
   PubMed Web of Science ®Google Scholar
• Ford, G.S., Barnhart, B., Shone, S. and Covey, L.R. (1999) "Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation", J. Immunol. 162, 4037–4044.
   PubMed Web of Science ®Google Scholar
• Barnhart, B., Kosinski, P.A., Wang, Z., Ford, G.S., Kiledjian, M. and Covey, L.R. (2000) "Identification of a complex that binds to the CD154untranslated region: implications for a role inmessage stability during T cell activation", J. Immunol. 165, 4478–4486.
   PubMed Web of Science ®Google Scholar
• Kosinski, P.A., Laughlin, J., Singh, K. and Covey, L.R. (2003) "A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA", J. Immunol. 170, 979–988.
   Google Scholar
• Hamilton, B.J., Genin, A., Cron, R.Q. and Rigby, W.F. (2003) "Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression", MoL Cell. Biol. 23, 510–525.
   PubMedGoogle Scholar
• Suarez, A., Mozo, L., Gayo, A., Zamorano, J. and Gutierrez, C. (1997) "Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mecha-nisms", Eur. J. Immunol. 27, 2822–2829.
   PubMedGoogle Scholar
• Rigby, W.F., Waugh, M.G. and Hamilton, B.J. (1999) "Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes", J. Immunol. 163, 4199–4206.
   PubMedGoogle Scholar
• Hsu, Y.M., Lucci, J., Su, L., Ehrenfels, B., Garber, E. and Thomas, D. (1997) "Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes", J. Biol. Chem. 272, 911–915.
   PubMed Web of Science ®Google Scholar
• Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R. and Neubauer, M. (1993) "The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome", Cell 72, 291–300.
   PubMed Web of Science ®Google Scholar
• Karpusas, M., Hsu, Y.M., Wang, J.H., Thompson, J., Lederman, S., Chess, L. and Thomas, D.W. (1995) "2 A crystal structure of an extracellular fragment of human CD40 ligand", Structure 3, 1426–1426.
   PubMed Web of Science ®Google Scholar
• Foy, TM., Aruffo, A., Bajorath, J., Buhlmann, J.E. and Noelle, R.J. (1996) "Immune regulation by CD40 and its ligand GP39", Ann. Rev. Immunol. 14, 591–617.
   PubMed Web of Science ®Google Scholar
• Bajorath, J., Marken, J.S., Chalupny, N.J., Spoon, T.L., Siadak, A.W., Gordon, M., Noelle, R.J., Hollenbaugh, D. and Aruffo, A. (1995) "Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis", Biochemistry 34, 9884–9892.
   Google Scholar
• Bajorath, J., Chalupny, N.J., Marken, J.S., Siadak, A.W., Skonier, J., Gordon, M., Hollenbaugh, D., Noelle, R.J., Ochs, H.D. and Aruffo, A. (1995) "Identification of residues on CD40 and its ligand which are critical for the receptor—ligand interaction", Biochemistry 34, 1833–1844.
   Google Scholar
• Garber, E., Su, L., Ehrenfels, B., Karpusas, M. and Hsu, Y.M. (1999) "CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals", J. Biol. Chem. 274, 33545–33550.
   PubMed Web of Science ®Google Scholar
• Matsuura, J.E., Morris, A.E., Ketchem, R.R., Braswell, E.H., Klinke, R., Gombotz, W.R. and Renunele, R.L., Jr. (2001) "Biophysical characterization of a soluble CD40 ligand (CD154) coiled-coil trimer: evidence of a reversible acid-denatured molten globule", Arch. Biochem. Biophys. 392, 208–218.
   Google Scholar
• Graf, D., Muller, S., Korthauer, U., Van Kooten, C., Weise, C. and Kroczek, R.A. (1995) "A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation", Eur. J. Immunol. 25, 1749–1754.
   PubMed Web of Science ®Google Scholar
• Mazzei, G.J., Edgerton, M.D., Losberger, C., Lecoanet-Henchoz, S., Graber, P., Durandy, A., Gauchat, J.E, Bernard, A., Allet, B. and Bonnefoy, J.Y. (1995) "Recombinant soluble trimeric CD40 ligand is biologically active", J. Biol. Chem. 270, 7025–7028.
   Google Scholar
• Pietravalle, F., Lecoanet-Henchoz, S., Blasey, H., Aubry, J.P., Elson, G., Edgerton, M.D., Bonnefoy, J.Y. and Gauchat, J.F. (1996) "Human native soluble CD4OL is a biologically active trimer, processed inside microsomes", J. Biol. Chem. 271, 5965–5967.
   PubMed Web of Science ®Google Scholar
• Pietravalle, F., Lecoanet-Henchoz, S., Aubry, J.P., Elson, G., Bonnefoy, J.Y. and Gauchat, J.F. (1996) "Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation", Eur. J. Immunol. 26, 725–728.
   PubMed Web of Science ®Google Scholar
• Ludewig, B., Henn, V., Schroder, J.M., Graf, D. and Kroczek, R.A. (1996) "Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells", Eur. J. Immunol. 26, 3137–3143.
   PubMed Web of Science ®Google Scholar
• Wykes, M., Poudrier, J., Lindstedt, R. and Gray, D. (1998) "Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells", Eur. J. Immunol., 548–559.
   Google Scholar
• Jin, I, Nonoyama, S., Mono, T., Imai, K., Ochs, RD. and Mizutani, S. (2001) "Characterization of soluble CD40 ligand released from human activated platelets", J. Med. Dent. Sci. 48, 23–27.
   PubMedGoogle Scholar
• Danese, S., Katz, J.A., Saibeni, S., Papa, A., Gasbarrini, A., Vecchi, M. and Fiocchi, C. (2003) "Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients", Gut 52, 1435–1441.
   PubMed Web of Science ®Google Scholar
• May, A.E., Kalsch, T., Massberg, S., Herouy, Y., Schmidt, R. and Gawaz, M. (2002) "Engagement of glycoprotein llbfllIa (alpha(11b)beta3) on platelets upregulates CD40L and triggers CD4OL-dependent matrix degradation by endothelial cells", Circulation 106, 2111–2117.
   PubMed Web of Science ®Google Scholar
• Viallard, J.F., Solanilla, A., Gauthier, B., Contin, C., Dechanet, J., Grosset, C., Moreau, J.F., Praloran, V., Nurden, P., Pellegrin, J.L., Nurden, A.T. and Ripoche, J. (2002) "Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis", Blood 99, 2612–2614.
   PubMedGoogle Scholar
• Nemoto, E., Tada, H. and Shimauchi, H. (2002) "Disruption of CD40/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production", J. Leukoc. Biol. 72, 538–545.
   Google Scholar
• Contin, C., Pitard, V., Itai, T., Nagata, S., Moreau, J.F. and Dechanet-Merville, J. (2003) "Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling", J. Biol. Chem. 278, 32801–32809.
   PubMed Web of Science ®Google Scholar
• Griggs, N.D., Agersborg, S.S., Noelle, R.J., Ledbetter, LA., Linsley, P.S. and Tung, KS. (1996) "The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells", J. Exp. Med. 183, 801–810.
   PubMed Web of Science ®Google Scholar
• Carayanniotis, G., Masters, S.R. and Noelle, R.J. (1997) "Suppression of murine thyroiditis via blockade of the CD40-CD4OL interaction", Immunology 90, 421–426.
   PubMed Web of Science ®Google Scholar
• Salmaso, C., Olive, D., Pesce, G. and Bagnasco, M. (2002) "Costimulatory molecules and autoinunune thyroid diseases", Autoimmunity 35, 159–167.
   PubMed Web of Science ®Google Scholar
• Kie, J.H., Cho, MS. and Yang, WI. (2001) "Expression of CD40 and apoptosis related molecules in autoimmune thyroid diseases", Yonsei Med. J. 42, 488–496.
   PubMed Web of Science ®Google Scholar
• Yu, S., Medling, B., Yagita, H. and Braley-Mullen, H. (2001) "Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice", J. Autoimmun. 16, 37–46.
   PubMed Web of Science ®Google Scholar
• Smith, T.J., Sciaky, D., Phipps, R.P. and Jennings, T.A. (1999) "CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases", Thyroid 9, 749–755.
   PubMed Web of Science ®Google Scholar
• Peterson, K.E. and Braley-Mullen, H. (1999) "CD4OL is necessary for the priming of effector cells for lymphocytic and granulo-matous experimental autoimmune thyroiditis", J. Autoimmun. 12, 1–12.
   PubMedGoogle Scholar
• Vandenbark, A.A., Hashim, G. and Offner, H. (1988) "Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein", Ann. NY Acad. Sci. 540, 337–339.
   Google Scholar
• Raine, C.S. and Dolich, M. (1986) "The anterior medullary velum and its involvement during autoimmune demyelination", J. Neurocytol. 15, 261–272.
   Google Scholar
• McDonald, A.H. and Swanborg, R.H. (1988) "Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis", J. Immunol. 140, 1132–1138.
   Google Scholar
• Peng, S.L., McNiff, J.M., Madaio, M.P., Ma, J., Owen, M.J., Flavell, R.A., Hayday, A.C. and Craft, J. (1997) "Alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity", J. Immunol. 158, 2464–2470.
   PubMed Web of Science ®Google Scholar
• Yellin, M.J., D'Agati, V., Parkinson, G., Han, AS., Szema, A., Baum, D., Estes, D., Szabolcs, M. and Chess, L. (1997) "Immunohistologic analysis of renal CD40 and CD4OL expression in lupus nephritis and other glomerulonephritides", Arthritis Rheum. 40, 124–134.
   Google Scholar
• Early, G.S., Zhao, W. and Burns, C.M. (1996) "Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response", J. Immunol. 157, 3159–3164.
   PubMed Web of Science ®Google Scholar
• Koshy, M., Berger, D. and Crow, M.K. (1996) "Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes", J. Clin. Investig. 98, 826–837.
   PubMed Web of Science ®Google Scholar
• Kalled, S.L., Cutler, A.H., Datta, S.K. and Thomas, D.W. (1998) "Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function", J. Immunol. 160, 2158–2165.
   PubMed Web of Science ®Google Scholar
• Boumpas, D.T., Furie, R., Manzi, S., Illei, G.G., Wallace, D.J., Balow, J.E. and Vaishnaw, A. (2003) "A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomeru-lonephritis", Arthritis Rheum. 48, 719–727.
   PubMed Web of Science ®Google Scholar
• Granuner, AC., Slota, R., Fischer, R., Gun, H., Girschick, H., Yarboro, C., Illei, G.G. and Lipsky, P.E. (2003) "Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions", J. Clin. Investig. 112, 1506–1520.
   Google Scholar
• Quezada, S.A., Eckert, M., Adeyi, 0.A., Schned, A.R., Noelle, R.J. and Burns, CM. (2003) "Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis", Arthritis Rheum. 48, 2541–2554.
   Google Scholar
• Davidson, A., Wang, X., Mihara, M., Ramanujam, M., Huang, W., Schiffer, L. and Sinha, J. (2003) "Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE)", Ann. NY Acad. Sci. 987, 188–198.
   PubMedGoogle Scholar
• Brams, P., Black, A., Padlan, E.A., Hariharan, K., Leonard, J., Chambers-Slater, K., Noelle, R.J. and Newman, R. (2001) "A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation", Int. Immuno-phannacol. 1, 277–294.
   PubMed Web of Science ®Google Scholar
• Wang, X., Huang, W., Schiffer, L.E., Mihara, M., Akkerman, A., Hiromatsu, K. and Davidson, A. (2003) "Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus", Arthritis Rheum. 48, 495–506.
   PubMed Web of Science ®Google Scholar
• Huang, W., Sinha, J., Newman, J., Reddy, B., Budhai, L., Furie, R., Vaishnaw, A. and Davidson, A. (2002) "The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythe-matosus", Arthritis Rheum. 46, 1554–1562.
   PubMed Web of Science ®Google Scholar
• Kairaitis, L., Wang, Y., Zheng, L., Tay, IC., Wang, Y. and Harris, D.C. (2003) "Blockade of CD4O—CD40 ligand protects against renal injury in chronic proteinuric renal disease", Kidney Int. 64, 1265–1272.
   PubMed Web of Science ®Google Scholar
• Dune, F.H., Fava, R.A., Foy, TM., Aruffo, A., Ledbetter, J.A. and Noelle, R.J. (1993) "Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40", Science 261, 1328–1330.
   PubMed Web of Science ®Google Scholar
• Haraoui, B., Strand, V. and Keystone, E. (2000) "Biologic agents in the treatment of rheumatoid arthritis", Curr. Phann. Biotechnol. 1, 217–233.
   Google Scholar
• Aarvak, T. and Natvig, J.B. (2001) "Cell—cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis", Arthritis Res. 3, 13–17.
   Google Scholar
• Kyburz, D., Carson, D.A. and Corr, M. (2000) "The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis", Arthritis Rheum. 43, 2571–2577.
   PubMed Web of Science ®Google Scholar
• Senior, K. (2000) "Anti-CD40 allays rheumatoid arthritis in mice", Lancet 355, 2054–2054.
   Google Scholar
• Mauri, C., Mars, L.T. and Londei, M. (2000) "Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process", Nat. Med. 6, 673–679.
   PubMed Web of Science ®Google Scholar
• MacDonald, K.P., Nishioka, I, Lipsky, P.E. and Thomas, R. (1997) "Functional CD40 ligand is expressed by T cells in rheumatoid arthritis", J. Clin. Investiig. 100, 2404–2414.
   PubMed Web of Science ®Google Scholar
• Gerritse, K., Laman, J.D., Noelle, R.J., Aruffo, A., Ledbetter, LA., Boersma, W.I. and Claassen, E. (1996) "CD4O—CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis", Proc. Natl Acad. Sci. USA 93, 2499–2504.
   PubMed Web of Science ®Google Scholar
• Grewal, IS., Foellmer, HG., Grewal, K.D., Xu, J., Hardardottir, F., Baron, J.L., Janeway, C.A., Jr. and Flavell, R.A. (1996) "Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis", Science 273, 1864–1867.
   PubMed Web of Science ®Google Scholar
• Samoilova, E.B., Horton, J.L., Zhang, H.D. and Chen, Y.H. (1997) "CD40L blockade prevents autoinunune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation", J. Mol. Med. 75, 603–608.
   PubMed Web of Science ®Google Scholar
• Laman, J.D., Maassen, C.B.M., Schellekens, MM., Visser, L., Kap, M., Dejong, E., Vanpuijenbroek, M., Vanstipdonk, M.J.B., Vanmeurs, M., Schwarzler, C. and Gunthert, U. (1998) "Therapy with antibodies against CD4OL (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide", Mult. Scler. 4, 147–153.
   Google Scholar
• Issazadeh, S., Navikas, V, Schaub, M., Sayegh, M. and Khoury, S. (1998) "Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo", J. Immunol. 161, 1104–1112.
   PubMed Web of Science ®Google Scholar
• Howard, L.M., Miga, A., Vanderlugt, CL., Dal Canto, M.C., Laman, J.D., Noelle, R.J. and Miller, S.D. (1999) "Mechanisms of immunotherapeutic intervention by anti-CD4OL (CD154) anti-body in an animal model of multiple sclerosis", J. Clin. Investig. 103, 281–290.
   PubMed Web of Science ®Google Scholar
• Howard, L.M., Dal Canto, M.C. and Miller, S.D. (2002) "Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses", J. Neuroimmunol. 129, 58–65.
   PubMed Web of Science ®Google Scholar
• Howard, L.M., Neville, K.L., Haynes, L.M., Dal Canto, M.C. and Miller, S.D. (2003) "CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease", J. Virol. 77, 2247–2250.
   Google Scholar
• Drescher, K.M., Zoecklein, L.J., Pavelko, K.D., Rivera-Quinones, C., Hollenbaugh, D. and Rodriguez, M. (2000) "CD4OL is critical for protection from demyelinating disease and development of spontaneous remyelination in a mouse model of multiple sclerosis", Brain Pathol. 10, 1–15.
   Google Scholar
• Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, HO. and Sarvetnick, N. (1997) "CD40 ligand—CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice", J. Immunol. 159, 4620–4627.
   PubMed Web of Science ®Google Scholar
• Jinchuan, Y, Zonggui, W., Jinming, C., Li, L. and Xiantao, K. (2004) "Upregulation of CD4O—CD40 ligand system in patients with diabetes mellitus", Clin. Chim. Acta 339, 85–90.
   PubMed Web of Science ®Google Scholar
• Molano, R.D., Pileggi, A., Berney, T., Poggioli, R., Zahr, E., Oliver, R., Ricordi, C., Rothstein, D.M., Basadonna, G.P. and Inverardi, L. (2003) "Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154", Diabetes 52, 957–964.
   PubMedGoogle Scholar
• Eshima, K., Mora, C., Wong, ES., Green, E.A., Grewal, IS. and Flavell, R.A. (2003) "A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse", Int. Immunol. 15, 351 —357.
   Google Scholar
• Moore, W.V., Chu, W., Tong, P.Y., Hess, D., Benjamin, C., Khalili, J. and Kover, K. (2002) "Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade", J. Autoimmun. 19, 139–145.
   Google Scholar
• Homann, D., Jahreis, A., Wolfe, T., Hughes, A., Coon, B., van Stipdonk, M.J., Prilliman, K.R., Schoenberger, S.P. and von Herrath, M.G. (2002) "CD4OL blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells", Immunity 16, 403–415.
   PubMedGoogle Scholar
• Wagner, D.H., Jr, Vaitaitis, G., Sanderson, R., Poulin, M., Dobbs, C. and Haskins, K. (2002) "Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes", Proc. Nall Acaa Sci. USA 99, 3782–3787.
   PubMed Web of Science ®Google Scholar
• Molano, R.D., Berney, T., Pileggi, A., Ricordi, C., Burkly, L., Rothstein, D., Basadonna, G. and Inverardi, L. (2001) "Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies", Transplant. Proc. 33, 248–249.
   PubMed Web of Science ®Google Scholar
• Im, S.H., Barchan, D., Maiti, P.K., Fuchs, S. and Souroujon, (2001) "Blockade of CD40 ligand suppresses chronic experi-mental myasthenia gravis by down-regulation of Th 1 differentiation and up-regulation of CTLA-4", J. Immunol. 166, 6893–6898.
   Google Scholar
• Padberg, F., Matsuda, M., Fenk, R., Patenge, N., Kubuschok, B., Hohlfeld, R., Wekerle, H. and Spuler, S. (1999) "Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures", Eur. J. Immunol. 29, 3538–3548.
   Google Scholar
• Christadoss, P., Poussin, M. and Deng, C. (2000) "Animal models of myasthenia gravis", Clin. Immunol. 94, 75–87.
   PubMed Web of Science ®Google Scholar
• Shi, F.D., He, B., Li, H., Matusevicius, D., Link, H. and Ljunggren, H.G. (1998) "Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis", Eur. J. Immunol. 28, 3587–3593.
   PubMed Web of Science ®Google Scholar
• Howard, L.M., Ostrovidov, S., Smith, CE., Dal Canto, MC. and Miller, S.D. (2002) "Normal Th 1 development following long-term therapeutic blockade of CD154—CD40 in experimental autoimmune encephalomyelitis", J. Clin. Investig. 109, 233–241.
   Google Scholar
• Vanderlugt, C.L., Begolka, W.S., Neville, K.L., Katz-Levy, Y., Howard, L.M., Eagar, T.N., Bluestone, J.A. and Miller, S.D. (1998) "The functional significance of epitope spreading and its regulation by co-stimulatory molecules", Immunol. Rev. 164, 63–72.
   PubMed Web of Science ®Google Scholar
• Girvin, A.M., Dal Canto, M.C. and Miller, S.D. (2002) "CD40/CD4OL interaction is essential for the induction of EAE in the absence of CD28-mediated costimulation", J. Autoimmun. 18, 83–94.
   Google Scholar
• Kenyon, N.S., Fernandez, L.A., Lehmann, R., Masetti, M., Ranuncoli, A., Chatzipetrou, M., Iaria, G., Han, D., Wagner, J.L., Ruiz, P., Berho, M., Inverardi, L., Alejandro, R., Mintz, D.H., Kirk, AD., Harlan, D.M., Burkly, L.C. and Ricordi, C. (1999) "Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154", Diabetes 48, 1473–1481.
   PubMed Web of Science ®Google Scholar
• Kenyon, N.S., Chatzipetrou, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J.L., Kirk, AD., Harlan, D.M., Burkly, L.C. and Ricordi, C. (1999) "Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154", Proc. Nail Acad. Sci. USA 96, 8132–8137.
   PubMed Web of Science ®Google Scholar
• Hussain, M.A. (2000) "CD154 for the dragon: a promising development for pancreatic islet transplantation and cure for type 1 diabetes mellitus", Eur. J. Endocrinol. 142, 111–113.
   Google Scholar
• Molano, RD., Berney, T., Li, H., Cattan, P., Pileggi, A., Vizzardelli, C., Kenyon, N.S., Ricordi, C., Burkly, L.C. and Inverardi, L. (2001) "Prolonged islet graft survival in NOD mice by blockade of the CD4O—CD154 pathway of T-cell costimula-tion", Diabetes 50, 270–276.
   PubMed Web of Science ®Google Scholar
• Rastellini, C., Salam, A., Kuddus, R., Aitouche, A., Subbotin, V, Braun, M., Leach, R., Peach, R., Fung, J.J., Starzl, T.E. and Rao, AS. (1999) "Prevention of T-cell activation by rhCTLA4-Ig and anti-CD4OL monoclonal antibody results in indefinite islet allograft survival", Transplant. Proc. 31, 1242–1243.
   Google Scholar
• Mach, F., Schonbeck, U., Sukhova, G.K., Bouncier, T., Bonnefoy, J.Y., Pober, J.S. and Libby, P. (1997) "Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD4O—CD40 ligand signaling in atherosclerosis", Proc. Natl Acad. Sci. USA 94, 1931–1936.
   PubMed Web of Science ®Google Scholar
• Mach, F., Schönbeck, U., Bonnefoy, J.Y., Pober, J.S. and Libby, P. (1997) "Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40-induction of collagenase, stromelysin, and tissue factor", Circulation 96, 396–399.
   PubMed Web of Science ®Google Scholar
• Schonbeck, U., Sukhova, G.K., Shimizu, K., Mach, F. and Libby, P. (2000) "Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice", Proc. Nall Acaa Sci. USA 97, 7458–7463.
   PubMed Web of Science ®Google Scholar
• Lutgens, E., Gorelik, L., Daemen, M.J., de Muinck, ED., Grewal, IS., Koteliansky, V.E. and Flavell, R.A. (1999) "Requirement for CD154 in the progression of atherosclerosis", Nat. Med. 5, 1313–1316.
   PubMed Web of Science ®Google Scholar
• Mach, F., Schonbeck, U., Sukhova, G.K., Atkinson, E. and Libby, P. (1998) "Reduction of atherosclerosis in mice by inhibition of CD40 signalling", Nature 394, 200–203.
   PubMed Web of Science ®Google Scholar
• Laman, J.D., de Boer, M. and Hart, BA. (1998) "CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis", Dev. Immunol. 6, 215–222.
   Google Scholar
• Lutgens, E., Cleutjens, KB., Heeneman, S., Koteliansky, Burkly, L.C. and Daemen, M.J. (2000) "Both early and delayed anti-CD4OL antibody treatment induces a stable plaque pheno-type", Proc. Natl Acad. Sci. USA 97, 7464–7469 (see comments).
   Google Scholar
• Kuwana, M., Nomura, S., Fujimura, K., Nagasawa, T., Muto, Y, Kurata, Y, Tanaka, S. and Ikeda, Y. (2003) "The effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura", Blood.
   Google Scholar
• Knosalla, C., Gollackner, B. and Cooper, D.K. (2002) "Anti-CD154 monoclonal antibody and thromboembolism revisted", Transplantation 74, 416–417.
   Google Scholar
• Buhler, L., Alwayn, I.P., Appel, 111, J.Z., Robson, S.C. and Cooper, D.K. (2001) "Anti-CD154 monoclonal antibody and thrombo-embolism", Transplantation 71, 491–491.
   PubMed Web of Science ®Google Scholar